Review: Glycosaminoglycans (GAGs) versus Cancer

Authors

  • Marina Mohd Sham Faculty of Industrial Sciences & Technology, Universiti Malaysia Pahang, 26300 Gambang, Kuantan, Pahang D. M., Malaysia.
  • Nina Suhaity Azmi Faculty of Industrial Sciences & Technology, Universiti Malaysia Pahang, 26300 Gambang, Kuantan, Pahang D. M., Malaysia.
  • Mohd Hasbi Ab. Rahim Faculty of Industrial Sciences & Technology, Universiti Malaysia Pahang, 26300 Gambang, Kuantan, Pahang D. M., Malaysia.

DOI:

https://doi.org/10.54987/jebat.v2i2.219

Keywords:

Cancer, tumor, glycosaminoglycans (GAGS), seafood, marine

Abstract

Cancer or tumor is a killer disease that brings mortality worldwide. Extracellular matrix (ECM) constituents involve in the potential growth, invasive and metastasis of the tumor cell through its interaction with cell-surface receptors, growth factors and cytokines. Thus, previous researchers came with a discovery of a potential anticancer compound known as glycosaminoglycans (GAGs). GAG is a polysachharide that plays an important role in physiological and pathological
conditions by affecting the cell properties and its functions. GAGs are majored from chondroitin sulfate (CS), dermatan sulfate (DS), keratan sulfate, heparin and heparan sulfate (HS), and hyaluronan which have their own important roles in cancer progression and cell signalling. Many researchers have reported the finding of GAGs in animal but there were least research of GAGs extraction from seafood and marine fauna. There are a few researches on extraction and analysis of GAGs from seafood wastes and marine lives such as white shrimp heads, mollusks and cuttlefish that showed the potential of GAGs as anticancer. Therefore, more researches on extraction of GAGs from seafoods need to be carried out as it can be anticancer therapeutic approaches for future prospective.

Downloads

Published

2014-12-31

How to Cite

Sham, M. M., Azmi, N. S., & Rahim, M. H. A. (2014). Review: Glycosaminoglycans (GAGs) versus Cancer. Journal of Environmental Bioremediation and Toxicology, 2(2), 58–61. https://doi.org/10.54987/jebat.v2i2.219

Issue

Vol. 2 No. 2 (2014)

Section

Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).